MannKind (MNKD)
Commercializes Afrezza, FUROSCIX and V-Go while manufacturing Tyvaso DPI for United Therapeutics.
$3.44
After hours−0.04 (−1.15%)
At close$3.48(−0.57%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$0.08
Revenue estimate
$110.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.03$0.04$0.00$0.03−$0.05−$0.05−$0.06Pending
Estimate$0.03$0.03$0.04$0.01−$0.01−$0.02−$0.01−$0.08
Surprise0.0%+33.3%−94.6%+200.0%−400.0%−150.0%−700.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$76.8M$78.4M$76.5M$82.1M$112.0M$90.2M$109.4MPending
Estimate$75.0M$78.4M$80.2M$99.9M$97.6M$105.4M$108.1M$110.3M
Surprise+2.4%−0.1%−4.5%−17.7%+14.7%−14.4%+1.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2028 | $0.25 | — | — |
| Jun 2028 | $0.02 | — | — |
| Mar 2028 | $0.02 | — | — |
| Dec 2027 | $0.05 | — | — |
| Sep 2027 | $0.08 | — | — |
| Jun 2027 | −$0.02 | — | — |
| Mar 2027 | −$0.02 | — | — |
| Dec 2026 | −$0.01 | — | — |
| Nov 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.01 | −$0.06 | −700.0% |
| May 2026 | −$0.02 | −$0.05 | −150.0% |
| Feb 2026 | −$0.01 | −$0.05 | −400.0% |
| Nov 2025 | $0.01 | $0.03 | +200.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2028 | $0.25 | — | — | $247.7M | — | — | — |
| Jun 2028 | $0.02 | — | — | $115.3M | — | — | — |
| Mar 2028 | $0.02 | — | — | $114.9M | — | — | — |
| Dec 2027 | $0.05 | — | — | $148.3M | — | — | — |
| Sep 2027 | $0.08 | — | — | $143.1M | — | — | — |
| Jun 2027 | −$0.02 | — | — | $140.9M | — | — | — |
| Mar 2027 | −$0.02 | — | — | $127.9M | — | — | — |
| Dec 2026 | −$0.01 | — | — | $133.6M | — | — | — |
| Nov 4, 2026 | −$0.08 | — | — | $110.3M | — | — | — |
| Aug 5, 2026 | −$0.01 | −$0.06 | −700.0% | $108.1M | $109.4M | +1.2% | −5.1% |
| May 6, 2026 | −$0.02 | −$0.05 | −150.0% | $105.4M | $90.2M | −14.4% | −0.3% |
| Feb 26, 2026 | −$0.01 | −$0.05 | −400.0% | $97.6M | $112.0M | +14.7% | −7.4% |
| Nov 5, 2025 | $0.01 | $0.03 | +200.0% | $99.9M | $82.1M | −17.7% | +10.6% |
| Aug 6, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 12, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |